Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.

Thust SC, Hassanein S, Bisdas S, Rees JH, Hyare H, Maynard JA, Brandner S, Tur C, Jäger HR, Yousry TA, Mancini L.

Eur Radiol. 2018 Sep;28(9):3779-3788. doi: 10.1007/s00330-018-5351-0. Epub 2018 Mar 23.

2.

Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.

Hyare H, Thust S, Rees J.

Curr Treat Options Neurol. 2017 Mar;19(3):11. doi: 10.1007/s11940-017-0445-6. Review.

PMID:
28349351
3.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJ, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R.

Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27.

4.

Acute demyelination following radiotherapy for glioma: a cautionary tale.

Milic M, Rees JH.

Pract Neurol. 2017 Jan;17(1):35-38. doi: 10.1136/practneurol-2016-001432. Epub 2016 Sep 9.

PMID:
27613277
5.

Diagnostic delay and survival in high-grade gliomas - evidence of the 'waiting time paradox'?

Aggarwal A, Herz N, Campbell P, Arkush L, Short S, Rees J.

Br J Neurosurg. 2015;29(4):520-3. doi: 10.3109/02688697.2015.1012050. Epub 2015 Mar 4.

PMID:
25738427
6.

Temozolomide in low-grade gliomas: living longer and better.

Rees J.

J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):359-60. doi: 10.1136/jnnp-2014-308880. Epub 2014 Sep 4. No abstract available.

PMID:
25189160
7.

Updates in the management of high-grade glioma.

Bradley D, Rees J.

J Neurol. 2014 Apr;261(4):651-4. doi: 10.1007/s00415-013-7032-x. Epub 2013 Jul 16. Review.

PMID:
23857040
8.

Diagnosis and treatment in neuro-oncology: an oncological perspective.

Rees JH.

Br J Radiol. 2011 Dec;84 Spec No 2:S82-9. doi: 10.1259/bjr/18061999. Review.

9.

The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas.

Sanghera P, Rampling R, Haylock B, Jefferies S, McBain C, Rees JH, Soh C, Whittle IR.

Clin Oncol (R Coll Radiol). 2012 Apr;24(3):216-27. doi: 10.1016/j.clon.2011.06.004. Epub 2011 Jul 23. Review.

PMID:
21783349
10.

Quantitative magnetisation transfer imaging in glioma: preliminary results.

Tozer DJ, Rees JH, Benton CE, Waldman AD, Jäger HR, Tofts PS.

NMR Biomed. 2011 Jun;24(5):492-8. doi: 10.1002/nbm.1614. Epub 2010 Oct 19.

PMID:
20960580
11.

Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force.

Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W; European Federation of Neurological Societies.

Eur J Neurol. 2010 Sep;17(9):1124-33. doi: 10.1111/j.1468-1331.2010.03151.x.

PMID:
20718851
12.

Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient.

Brasil Caseiras G, Ciccarelli O, Altmann DR, Benton CE, Tozer DJ, Tofts PS, Yousry TA, Rees J, Waldman AD, Jäger HR.

Radiology. 2009 Nov;253(2):505-12. doi: 10.1148/radiol.2532081623. Epub 2009 Sep 29.

PMID:
19789244
13.

Quantitative imaging biomarkers in neuro-oncology.

Waldman AD, Jackson A, Price SJ, Clark CA, Booth TC, Auer DP, Tofts PS, Collins DJ, Leach MO, Rees JH; National Cancer Research Institute Brain Tumour Imaging Subgroup.

Nat Rev Clin Oncol. 2009 Aug;6(8):445-54. doi: 10.1038/nrclinonc.2009.92. Epub 2009 Jun 23. Review.

PMID:
19546864
14.

Astrocytoma derived short-term cell cultures retain molecular signatures characteristic of the tumour in situ.

Potter NE, Phipps K, Harkness W, Hayward R, Thompson D, Jacques TS, Harding B, Thomas DG, Rees J, Darling JL, Warr TJ.

Exp Cell Res. 2009 Oct 1;315(16):2835-46. doi: 10.1016/j.yexcr.2009.06.003. Epub 2009 Jun 10.

PMID:
19523942
15.

Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.

Caseiras GB, Chheang S, Babb J, Rees JH, Pecerrelli N, Tozer DJ, Benton C, Zagzag D, Johnson G, Waldman AD, Jäger HR, Law M.

Eur J Radiol. 2010 Feb;73(2):215-20. doi: 10.1016/j.ejrad.2008.11.005. Epub 2009 Feb 6.

PMID:
19201123
16.

Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.

Potter N, Karakoula A, Phipps KP, Harkness W, Hayward R, Thompson DN, Jacques TS, Harding B, Thomas DG, Palmer RW, Rees J, Darling J, Warr TJ.

Neoplasia. 2008 Aug;10(8):757-72.

17.

Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.

Rees J, Watt H, Jäger HR, Benton C, Tozer D, Tofts P, Waldman A.

Eur J Radiol. 2009 Oct;72(1):54-64. doi: 10.1016/j.ejrad.2008.06.013. Epub 2008 Jul 15.

PMID:
18632238
18.

Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference?

Caseiras GB, Thornton JS, Yousry T, Benton C, Rees J, Waldman AD, Jäger HR.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1140-1. doi: 10.3174/ajnr.A0993. Epub 2008 Apr 3.

19.

Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR.

Radiology. 2008 Apr;247(1):170-8. doi: 10.1148/radiol.2471062089.

PMID:
18372467
20.

Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas.

Tofts PS, Benton CE, Weil RS, Tozer DJ, Altmann DR, Jäger HR, Waldman AD, Rees JH.

J Magn Reson Imaging. 2007 Jan;25(1):208-14.

PMID:
17139631

Supplemental Content

Loading ...
Support Center